We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

137 hedge funds and large institutions have $329M invested in Spectrum Pharmaceuticals Inc in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 34 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

50% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 34

8% more funds holding

Funds holding: 127137 (+10)

8% less capital invested

Capital invested by funds: $359M → $329M (-$29.5M)

80% less call options, than puts

Call options by funds: $311K | Put options by funds: $1.58M

Holders
137
Holders Change
+10
Holders Change %
+7.87%
% of All Funds
3.65%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
25
Increased
51
Reduced
34
Closed
12
Calls
$311K
Puts
$1.58M
Net Calls
-$1.27M
Net Calls Change
-$113K
Name Holding Trade Value Shares
Change
Change in
Stake
BA
26
BlackRock Advisors
Delaware
$2.26M +$742K +100,920 +45%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$1.97M +$696K +94,700 +50%
Ameriprise
28
Ameriprise
Minnesota
$1.95M +$51.9K +7,064 +3%
Deutsche Bank
29
Deutsche Bank
Germany
$1.95M +$126K +17,083 +6%
TCIM
30
TIAA CREF Investment Management
New York
$1.88M -$62.2K -8,457 -3%
Renaissance Technologies
31
Renaissance Technologies
New York
$1.72M +$1.82M +248,000 New
BIM
32
BlackRock Investment Management
Delaware
$1.68M -$18.2K -2,471 -1%
BA
33
Bard Associates
Illinois
$1.56M -$178K -24,160 -10%
NCCM
34
Nine Chapters Capital Management
New Jersey
$1.55M +$922K +125,400 +127%
IIM
35
Ironwood Investment Management
Massachusetts
$1.53M +$133K +18,092 +9%
SIM
36
Spark Investment Management
New York
$1.46M +$1.01M +137,100 +185%
TC
37
TFS Capital
Pennsylvania
$1.35M +$603K +81,939 +73%
FLAM
38
First Light Asset Management
Minnesota
$1.3M -$1.4M -190,365 -50%
PP
39
PDT Partners
New York
$1.27M -$383K -52,100 -22%
Thrivent Financial for Lutherans
40
Thrivent Financial for Lutherans
Minnesota
$1.27M -$83.1K -11,300 -6%
CS
41
Credit Suisse
Switzerland
$1.24M +$708K +96,279 +118%
DMK
42
David M. Knott
$1.09M +$40.4K +5,500 +4%
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
$1.08M -$9.99M -1,358,908 -90%
NFA
44
Nationwide Fund Advisors
Ohio
$1.03M +$82.7K +11,242 +8%
Invesco
45
Invesco
Georgia
$1.02M -$50.5K -6,862 -4%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$996K -$190K -25,883 -15%
GC
47
Globeflex Capital
California
$994K +$419 +57 +0%
SEI Investments
48
SEI Investments
Pennsylvania
$891K +$946K +128,607 New
Prudential Financial
49
Prudential Financial
New Jersey
$883K +$55.9K +7,600 +6%
AIG
50
American International Group
New York
$868K +$27.8K +3,778 +3%

SPPI Hedge Fund Activity: Q4 2014 in Review

137 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2014, worth a combined $329M — down 8.2% from $359M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SPPI positions and 12 closed out — a net gain of 13 holders — while 51 added to existing stakes and 34 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $4.54M. The largest seller was Bank of Montreal, cutting an estimated $9.99M.

  • 137 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2014, up from 127 in Q3 2014.
  • Funds reported $329M of Spectrum Pharmaceuticals Inc stock for Q4 2014, down 8.2% quarter-over-quarter.
  • 25 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2014 and 12 closed out, a net change of +13 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $4.54M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q4 2014 was Bank of Montreal, an estimated $9.99M sold.

Based on aggregated 13F filings for Q4 2014.